February 25, 2021

Humira Ulcerative Colitis Indication Expanded to Include Children

Read More
February 22, 2021

Libtayo Receives New Lung Cancer Indication

Read More
February 22, 2021

AstraZeneca Withdraws Imfinzi Bladder Cancer Indication

Read More
February 17, 2021

FDA Partially Rescinds Approvals for Two Hemophilia B Treatments

Read More
February 16, 2021

Entresto Receives Expanded Heart Failure Indication

Read More
February 16, 2021

FDA Issues Warning to AcelRx for False and Misleading Promotion of Dsuvia

Read More
February 12, 2021

Panzyga Receives New Indication for Rare Nervous System Disorder

Read More
February 12, 2021

Cosela Approved to Reduce Myelosuppression from Chemotherapy

Read More
February 12, 2021

Zirabev Receives New Indication for Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancers

Read More
February 11, 2021

First-in-Class Drug Evkeeza Approved to Treat Rare Inherited Form of High Cholesterol

Read More
February 11, 2021

Over-the-Counter Nasal Spray Recalled Due to Yeast Contamination

Read More
February 10, 2021

Botox Receives New Pediatric Indication

Read More